FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

ESTEE LAUDER DayWear Sheer Tint Release Recall

ESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant Moistu…

Estee Lauder Inc · New York, NY

Risk level
Class III
Reported by FDA
Feb 13, 2013
Recall ID
D-151-2013
Check your lot numberHow we source this data

Summary

Estee Lauder recalled ESTEE LAUDER DayWear Sheer Tint Release starting Oct 23, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-151-2013 on Feb 13, 2013. Reason: Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled. Status: Terminated.

Why it was recalled

Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.

Product description

ESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant Moisturizer Broad Spectrum SPF15, All Skin types, 1.7 FL. OZ. LIQ/50 ml (tube inside a unit carton) with UPC No. 2713179904, Code WKEM-01, and 1.5 mL foil sample packets, ESTEE LAUDER, DIST., NEW YORK, N.Y. 10022 NDC 11559-008-01

Lot numbers, UPCs & expiration codes

A70, A80, AA0, B11, A31, A51, B51, A81, A91, A12, A22, A72, BA0, AB0, BB0, CB0, AC0, BC0, A11, A21, B21, B31, A41.

Where it was sold

Nationwide, Puerto Rico, Bermuda and Panama

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-151-2013
Classification
Class III
Status
Terminated
Recall initiated
Oct 23, 2012
FDA report date
Feb 13, 2013
Quantity
1.7 oz. 241,236 tubes; 1.5 mL sample size 544,548 foil packs
Recall type
Voluntary: Firm initiated
Recalling firm
Estee Lauder Inc

Original FDA data

Every field from FDA enforcement report D-151-2013, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
63510
Address
767 5th Ave Fl 47th
Code information
A70, A80, AA0, B11, A31, A51, B51, A81, A91, A12, A22, A72, BA0, AB0, BB0, CB0, AC0, BC0, A11, A21, B21, B31, A41.
Postal code
10153-0023
Report date
Feb 13, 2013
Product type
Drugs
Recall number
D-151-2013
Classification
Class III
Recalling firm
Estee Lauder Inc
Product quantity
1.7 oz. 241,236 tubes; 1.5 mL sample size 544,548 foil packs
Termination date
Apr 3, 2017
Reason for recall
Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant Moisturizer Broad Spectrum SPF15, All Skin types, 1.7 FL. OZ. LIQ/50 ml (tube inside a unit carton) with UPC No. 2713179904, Code WKEM-01, and 1.5 mL foil sample packets, ESTEE LAUDER, DIST., NEW YORK, N.Y. 10022 NDC 11559-008-01
Distribution pattern
Nationwide, Puerto Rico, Bermuda and Panama
Recall initiation date
Oct 23, 2012
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Feb 5, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-151-2013, published Feb 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls